SCHEMBL6372184

SCHEMBL6372184

CSCC[C@@H](C(=O)O)N(C)C(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.47
ABCB1 P08183 2/20 0.46
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
CTSK P43235 2/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSS P25774 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MME P08473 1/20 0.41
ANPEP P15144 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11306029 0.85 FOLH1 (0.49) FOLH1ABCB1ITGB3ITGA2BCTSK
SCHEMBL3644349 0.85 ALDH1A1 (0.44) FOLH1ABCB1ALDH1A1MMEANPEP
SCHEMBL2820532 0.84 FOLH1 (0.45) FOLH1ABCB1ITGB3ITGA2BCTSK
SCHEMBL2820537 0.84 FOLH1 (0.45) FOLH1ABCB1ITGB3ITGA2BCTSK
SCHEMBL25183100 0.84 CTSK (0.51) FOLH1ABCB1ITGB3ITGA2BCTSK
SCHEMBL6420482 0.84 FOLH1 (0.48) FOLH1ABCB1ITGB3ITGA2BCTSK
SCHEMBL7087077 0.84 FOLH1 (0.63) FOLH1ABCB1ITGB3ITGA2BCTSK
SCHEMBL24447455 0.84 CTSK (0.51) FOLH1ABCB1ITGB3ITGA2BCTSK
SCHEMBL28404302 0.84 FOLH1 (0.63) FOLH1ABCB1ITGB3ITGA2BCTSK
SCHEMBL25177917 0.83 CTSK (0.47) FOLH1ABCB1ITGB3ITGA2BCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118459369-A Synthetic method of N-Boc-vinyl glycine methyl ester and isomer thereof 成都师范学院 2024-08-09 CN disclosed
US-20050245432-A1 N-methyl amino acids UBIQUITOUS TECHNOLOGIES PTY. LTD. (AU) 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245432-A1 N-methyl amino acids VIP, NPPA, PTMS FOLH1 295/4885ABCB1 4149/4885ITGB3 3285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.